Prevention of intravenous contrast-induced nephropathy in hospital inpatients.
Intravenous contrast-induced nephropathy (CIN) is associated with significant in-hospital morbidity. Numerous studies examining various contrast agents and the risks of CIN have identified associated risk factors. A body of literature has emerged identifying strategies to reduce the incidence of CIN in at-risk patients. On the basis of the recently published clinical trial data and guidelines from the major radiologic societies, we developed an algorithmic approach to CIN prophylaxis in hospital inpatients.
Kakkar
Rahul
R
Department of Medicine, Brigham and Women's Hospital, 75 Francis Street, Boston, Massachusetts 02115, USA. rkakkar@partners.org
Sobieszczyk
Piotr
P
Binkert
Christoph A
CA
Faxon
David P
DP
Mortele
Koenraad J
KJ
Singh
Ajay K
AK
D058186:Acute Kidney Injury / Q000139:chemically induced* / Q000401:mortality / Q000517:prevention & control*; D000368:Aged; D015906:Angioplasty, Balloon, Coronary / Q000009:adverse effects / Q000379:methods; D003287:Contrast Media / Q000009:adverse effects*; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D017052:Hospital Mortality / Q000639:trends*; D006801:Humans; D007275:Injections, Intravenous; D007297:Inpatients; D007677:Kidney Function Tests; D008297:Male; D008875:Middle Aged; D011322:Primary Prevention / Q000379:methods; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D015996:Survival Rate
D003287:Contrast Media